According to Zydus Lifesciences's latest financial reports the company has a price-to-book ratio of 3.03.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 2.23 | -17.95% |
2021-12-31 | 2.72 | -24.72% |
2020-12-31 | 3.61 | 62.62% |
2019-12-31 | 2.22 | -45.2% |
2018-12-31 | 4.05 | -30.23% |
2017-12-31 | 5.81 | 6.28% |
2016-12-31 | 5.47 | -15.44% |
2015-12-31 | 6.46 | -17.13% |
2014-12-31 | 7.80 | 53.22% |
2013-12-31 | 5.09 | -14.69% |
2012-12-31 | 5.97 |